Literature DB >> 19604115

Peptides of a novel Mycobacterium tuberculosis-specific cell wall protein for immunodiagnosis of tuberculosis.

Krishna K Singh1, Naresh Sharma, Diana Vargas, Zhentong Liu, John T Belisle, Visalakshi Potharaju, Ajay Wanchu, Digambar Behera, Suman Laal.   

Abstract

The sequencing of the Mycobacterium tuberculosis genome revealed the existence of several genes encoding novel proteins with unknown functions, one of which is the proline-threonine repetitive protein (PTRP; Rv0538). Genomic studies of various mycobacterial species and M. tuberculosis clinical isolates demonstrate that ptrp is specific to the M. tuberculosis complex and ubiquitous in clinical isolates. Enzyme-linked immunosorbent assay, Western blot analysis, and electron microscopic evaluation of M. tuberculosis subcellular fractions and intact bacteria confirm that PTRP is a cell wall protein. Antibodies to PTRP are present in serum specimens from human immunodeficiency virus (HIV)-negative, tuberculosis (TB)-positive and HIV-positive, TB-positive patients but not purified protein derivative (PPD)-negative or PPD-positive healthy control subjects, demonstrating its diagnostic potential. Epitope mapping of PTRP delineated 4 peptides that can identify >80% of sputum smear-positive and >50% of smear-negative, HIV-negative, TB-positive patients and >80% of HIV-positive, TB-positive patients. These results demonstrate that immunodominant epitopes of carefully selected M. tuberculosis-specific proteins can be used to devise a simple peptide-based serodiagnostic test for TB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19604115      PMCID: PMC2846530          DOI: 10.1086/603539

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Bacterial and host-derived cationic proteins bind alpha2-laminins and enhance Mycobacterium leprae attachment to human Schwann cells.

Authors:  M A de Melo Marques; S Mahapatra; D Nandan; T Dick; E N Sarno; P J Brennan; M C Vidal Pessolani
Journal:  Microbes Infect       Date:  2000-10       Impact factor: 2.700

2.  The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.

Authors:  K Pethe; S Alonso; F Biet; G Delogu; M J Brennan; C Locht; F D Menozzi
Journal:  Nature       Date:  2001-07-12       Impact factor: 49.962

3.  Comparison of the proteome of Mycobacterium tuberculosis strain H37Rv with clinical isolate CDC 1551.

Authors:  J C Betts; P Dodson; S Quan; A P Lewis; P J Thomas; K Duncan; R A McAdam
Journal:  Microbiology       Date:  2000-12       Impact factor: 2.777

4.  Homogeneity of antibody responses in tuberculosis patients.

Authors:  K Samanich; J T Belisle; S Laal
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

5.  Mapping and identification of Mycobacterium tuberculosis proteins by two-dimensional gel electrophoresis, microsequencing and immunodetection.

Authors:  I Rosenkrands; K Weldingh; S Jacobsen; C V Hansen; W Florio; I Gianetri; P Andersen
Journal:  Electrophoresis       Date:  2000-03       Impact factor: 3.535

6.  Comparative proteome analysis of culture supernatant proteins from virulent Mycobacterium tuberculosis H37Rv and attenuated M. bovis BCG Copenhagen.

Authors:  Jens Mattow; Ulrich E Schaible; Frank Schmidt; Kristine Hagens; Frank Siejak; Gordon Brestrich; Gisela Haeselbarth; Eva-Christina Müller; Peter R Jungblut; Stefan H E Kaufmann
Journal:  Electrophoresis       Date:  2003-10       Impact factor: 3.535

Review 7.  Virological and immunological impact of tuberculosis on human immunodeficiency virus type 1 disease.

Authors:  Zahra Toossi
Journal:  J Infect Dis       Date:  2003-09-30       Impact factor: 5.226

8.  Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain.

Authors:  Sheng Gu; Jin Chen; Karen M Dobos; E Morton Bradbury; John T Belisle; Xian Chen
Journal:  Mol Cell Proteomics       Date:  2003-10-06       Impact factor: 5.911

Review 9.  Immunodiagnosis of parasitic diseases with synthetic peptides.

Authors:  O Noya; M E Patarroyo; F Guzmán; B Alarcón de Noya
Journal:  Curr Protein Pept Sci       Date:  2003-08       Impact factor: 3.272

Review 10.  Synthetic peptides in the diagnosis of HIV infection.

Authors:  Maria Claudia Alcaro; Elisa Peroni; Paolo Rovero; Anna Maria Papini
Journal:  Curr Protein Pept Sci       Date:  2003-08       Impact factor: 3.272

View more
  6 in total

1.  Correlation between serum and plasma antibody titers to mycobacterial antigens.

Authors:  Michael Siev; Xian Yu; Rafael Prados-Rosales; Frank T Martiniuk; Arturo Casadevall; Jacqueline M Achkar
Journal:  Clin Vaccine Immunol       Date:  2010-11-03

2.  Variation among genome sequences of H37Rv strains of Mycobacterium tuberculosis from multiple laboratories.

Authors:  Thomas R Ioerger; Yicheng Feng; Krishna Ganesula; Xiaohua Chen; Karen M Dobos; Sarah Fortune; William R Jacobs; Valerie Mizrahi; Tanya Parish; Eric Rubin; Chris Sassetti; James C Sacchettini
Journal:  J Bacteriol       Date:  2010-05-14       Impact factor: 3.490

3.  LipC (Rv0220) is an immunogenic cell surface esterase of Mycobacterium tuberculosis.

Authors:  Guomiao Shen; Krishna Singh; Dinesh Chandra; Carole Serveau-Avesque; Damien Maurin; Stéphane Canaan; Rupak Singla; Digambar Behera; Suman Laal
Journal:  Infect Immun       Date:  2011-10-28       Impact factor: 3.441

4.  Proposing low-similarity peptide vaccines against Mycobacterium tuberculosis.

Authors:  Guglielmo Lucchese; Angela Stufano; Darja Kanduc
Journal:  J Biomed Biotechnol       Date:  2010-06-03

5.  Diagnostic potential of 16 kDa (HspX, α-crystalline) antigen for serodiagnosis of tuberculosis.

Authors:  Amit Kaushik; Urvashi B Singh; Chhavi Porwal; Shwetha J Venugopal; Anant Mohan; Anand Krishnan; Vinay Goyal; Jayant N Banavaliker
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

6.  Development of a POC test for TB based on multiple immunodominant epitopes of M. tuberculosis specific cell-wall proteins.

Authors:  Jesus M Gonzalez; Bryan Francis; Sherri Burda; Kaitlyn Hess; Digamber Behera; Dheeraj Gupta; Ashutosh Nath Agarwal; Indu Verma; Ajoy Verma; Vithal Prasad Myneedu; Sam Niedbala; Suman Laal
Journal:  PLoS One       Date:  2014-09-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.